Real World Experience in Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Lack of Anti-Drug Antibodies to Vedolizumab and Ustekinumab Compared to Anti-TNF Agents in IBD

2018 ◽  
Vol 113 (Supplement) ◽  
pp. S343-S344
Author(s):  
Kerri L. Glassner ◽  
Ayah Oglat ◽  
Bincy Abraham
Keyword(s):  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Real World ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Inflammatory Bowel

Therapeutic Drug Monitoring of Biologics in Patients With Inflammatory Bowel Disease: A Real World Experience

2018 ◽  
Vol 113 (Supplement) ◽  
pp. S416-S417
Author(s):  
Chris Fourment ◽  
Timothy E. Ritter ◽  
Schroeder P. Claudia ◽  
Tracy C. Okoro ◽  
Lucinda J. Van Anglen
Keyword(s):  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Real World ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Inflammatory Bowel

Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease

2020 ◽  
Vol 65 (4) ◽  
Author(s):  
Daniela Pugliese ◽  
Giuseppe Privitera ◽  
Fabrizio Pizzolante ◽  
Antonio Gasbarrini ◽  
Luisa Guidi ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Inflammatory Bowel

scholarly journals P546 Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease

2019 ◽  
Vol 13 (Supplement_1) ◽  
pp. S387-S387
Author(s):  
N Torres ◽  
D Martín Arranz ◽  
M Sánchez Azofra ◽  
E Martín Arranz ◽  
L Garcia ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document